In the past week, major proxy advisors ISS and Glass Lewis, along with large shareholders, publicly opposed CoreWeave’s proposed US$9 billion all-stock acquisition of Core Scientific, citing concerns ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback